|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Catalysing delivery of novel and targeted therapeutics from human genetics
If you have a question about this talk, please contact dff21.
Abstract not available
This talk is part of the Cambridge Cardiovascular Seminar Series series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsInstitute Seminar Biotech Talks- Dept of Biochemistry Type the title of a new list here
Other talksMerck, Sharp & Dohme Lecture Dr Frank Waldron-Lynch: Immune Cell Responses in Participants with Type 1 Diabetes after doses of Interleukin-2 in adaptive-response clinical trials How will the storm tracks change? High resolution studies of the future of extratropical storm tracks Creating the right environment for dialogue-learning, policy and practice improvement in health and social care Predicting the pleiotropic effects of circadian timing, from clock gene expression to biomass. Buckling of Spherical Shells Revisited